|
2024
|
G/S
|
Medical apparatuses |
|
|
G/S
|
Medical apparatus and devices. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cardiovascular, metabolic, hematological, immuno... |
|
|
G/S
|
Platform as a service (PAAS) featuring computer software platforms for genetic research and scien... |
|
|
G/S
|
Business administration services, namely, business administration of a program to provide access ... |
|
|
G/S
|
Platform as a service (PAAS) featuring computer software platforms for genetic research and gene ... |
|
|
Invention
|
Transgenic mice with humanized mhc i and immunoglobluin heavy chain genes.
A non-human animal is... |
|
|
Invention
|
Models of tauopathy.
BANF1, PPP2CA, and ANKLE2 were identified as genes that promote tau aggrega... |
|
|
Invention
|
Novel il2 agonists and methods of use thereof.
The present disclosure relates to IL2 agonists wi... |
|
|
Invention
|
Anti-pfrh5 antibodies and antigen-binding fragments thereof.
The present invention includes anti... |
|
|
Invention
|
Genetically modified mouse that expresses humanized pd1 and pd-l1 proteins.
Non-human animals, m... |
|
|
Invention
|
Methods for quantifying il-33.
Methods and compositions for detecting and quantifying cytokines ... |
|
|
Invention
|
Non-human animals having a humanized lymphocyte-activation gene 3.
Non-human animals, and method... |
|
|
Invention
|
Antibody resistant modified receptors to enhance cell-based therapies.
Methods for improving eng... |
|
|
Invention
|
Anti-c5 antibodies combinations and uses thereof.
The present invention relates to combinations ... |
|
|
G/S
|
Capital investment; investment management; equity capital investment; providing venture capital, ... |
|
|
G/S
|
Capital investment; investment management; equity capital
investment; providing venture capital,... |
|
|
Invention
|
Hydrophilic linkers for antibody drug conjugates.
Described herein protein drug conjugates and c... |
|
|
Invention
|
Anti-cd8 antibodies and uses thereof.
Anti-CD8 antibodies, radiolabeled anti-CD8 antibodies, flu... |
|
|
Invention
|
Viral clearance by low ph hold.
Methods for viral clearance using low pH hold based on a statist... |
|
|
G/S
|
Medical apparatuses |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of diseases, namely, genetic disease... |
|
|
Invention
|
Methods of analyzing and characterizing messenger ribonucleic acid (mrna) and polyadenylation on ... |
|
|
Invention
|
Methods and compositions for increasing homology-directed repair. Provided herein are combination... |
|
|
Invention
|
Process for reducing subvisible particles in a pharmaceutical formulation.
The present disclosur... |
|
|
G/S
|
Medical assistance services in the field of treatment of cardiovascular diseases; Providing medic... |
|
|
Invention
|
Target residual moisture content for lyophilized drug product.
Lyophilization methods for prepar... |
|
|
Invention
|
Extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders. The prese... |
|
|
Invention
|
Methods for purifying filled adeno-associated virus capsids. The inventions provide methods of pu... |
|
|
Invention
|
Methods for purifying filled adeno-associated virus capsids.
The inventions provide methods of p... |
|
|
Invention
|
Auto-injector and related methods of use.
In one instance, disclosed herein is an auto-injector,... |
|
|
Invention
|
Auto-injector and related methods of use. In one instance, disclosed herein is an auto-injector, ... |
|
|
Invention
|
Proprotein convertase subtilisin/kexin type 1 (pcsk1) variants and uses thereof.
Methods of trea... |
|
|
Invention
|
Host cell protein analysis for adeno-associated virus (aav)-based gene therapy. The present inven... |
|
|
Invention
|
Host cell protein analysis for adeno-associated virus (aav)-based gene therapy.
The present inve... |
|
|
Invention
|
Auto-injector and related methods of use.
An auto-injector, including a housing and a cartridge ... |
|
|
Invention
|
Medical device packaging and related methods.
A packaging comprising a tray having a body surrou... |
|
|
Invention
|
Cd40 x cd40 bispecific antigen-binding molecules and uses thereof. The present disclosure provide... |
|
|
Invention
|
Auto-injector and related methods of use. An auto-injector, including a housing and a cartridge d... |
|
|
Invention
|
Medical device packaging and related methods. A packaging comprising a tray having a body surroun... |
|
|
Invention
|
Vectors, genetically modified cells, and genetically modified non-human animals comprising the sa... |
|
|
Invention
|
Gene therapy for hearing disorders. The present disclosure provides polynucleotides containing re... |
|
|
Invention
|
Systems, devices, and methods of a data pipeline.
Disclosed are data pipelines for string extrac... |
|
|
Invention
|
Systems, devices, and methods of a data pipeline. Disclosed are data pipelines for string extract... |
|
|
Invention
|
Circularized antibody molecules. The present disclosure provides circularized antibody molecules ... |
|
|
Invention
|
Animal model with rapid onset of alzheimer's amyloid beta plaque pathology.
Provided herein are ... |
|
|
Invention
|
Animal model with rapid onset of alzheimer's amyloid beta plaque pathology. Provided herein are c... |
|
|
Invention
|
Low affinity fcyr deficient mice.
Genetically modified non-human animals and methods and composi... |
|
|
Invention
|
Anti-il-33 antibodies and uses thereof.
The present invention provides antibodies that bind to i... |
|
|
Invention
|
Anti-pdgf-b antibodies and pharmaceutical composition thereof.
The present disclosure provides a... |
|
|
Invention
|
Methods of increasing strength and functionality with gdf8 inhibitors.
The disclosure provides c... |
|
|
Invention
|
T cell receptors that bind presented hpv16-, mart1-, cmv-, ebv-, or influenza- peptides. Describe... |
|
|
Invention
|
Auto-injector and related methods of use.
A training device may include a housing having a tissu... |
|
|
G/S
|
Medical and pharmaceutical consultation; Medical assistance services; Medical information |
|
|
G/S
|
Anti-inflammatory preparations; anti-viral agents; pharmaceutical anti-allergic preparations and ... |
|
|
G/S
|
Capital investment; Investment management; Equity capital investment; Providing venture capital, ... |
|
|
Invention
|
Systems and methods for correcting for noise and systemic variations in sequencing data.
The dis... |
|
2022
|
Invention
|
Cd20-pd1 binding molecules and methods of use thereof.
The present disclosure relates to molecul... |
|
|
Invention
|
Crispr/cas-related methods and compositions for knocking out c5.
Guide RNAs and CRISPR/Cas syste... |
|
|
Invention
|
Stereocilin promoters and uses thereof.
The disclosure provides stereocilin (STRC) promoters, as... |
|
|
Invention
|
Irna compositions and methods for targeting angptl7.
The disclosure relates to double-stranded r... |
